ImmuCell Q4 Earnings Call Highlights [Yahoo! Finance]
ImmuCell Corporation (ICCC)
US:NASDAQ Investor Relations:
immucell.com/investors
Company Research
Source: Yahoo! Finance
Management said the company will pause investment in Re-Tain, its long-developed mastitis treatment candidate, following an FDA “Incomplete Letter” that management attributed solely to issues at the contract manufacturer responsible for aseptic filling. President and CEO Oliver Taboukos said the company is “shifting our strategy as a company to focus on First Defense” and suspending investment in manufacturing Re-Tain. Taboukos framed the decision around two factors: confidence in First Defense's growth potential and the practical effect of the FDA's Incomplete Letter for Re-Tain's new animal drug application. ? Flying Cars and Rising Bars: The 2026 eVTOL Breakout Begins According to Taboukos, the Incomplete Letter means ImmuCell is “still years away, rather than just months away,” from an FDA-compliant manufacturing solution necessary for launch. He said that continuing to invest in Re-Tain would have required increased expenses and capital investment, which management believes
Show less
Read more
Impact Snapshot
Event Time:
ICCC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ICCC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ICCC alerts
High impacting ImmuCell Corporation news events
Weekly update
A roundup of the hottest topics
ICCC
News
- ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025 [Yahoo! Finance]Yahoo! Finance
- ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025GlobeNewswire
- ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus [Yahoo! Finance]Yahoo! Finance
- ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in FocusGlobeNewswire
- ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain® [Yahoo! Finance]Yahoo! Finance
ICCC
Sec Filings
- 1/8/26 - Form 8-K
- 12/29/25 - Form 8-K
- 12/4/25 - Form 4/A
- ICCC's page on the SEC website